Tag: pharmaceuticals
-

Trial to Test Engineered Amino Acid for Schizophrenia
A clinical trial plans to test a modified amino acid as an added treatment for schizophrenia that its developers say works differently than most current drugs.
-

Engineered Virus Aids Gene Therapy Delivery
A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies.
-

Biotech Licenses Gene-Limiting Technology for Allergies
A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions.
-

Company, Univ. Lab Partner on Skin Disease Treatment
A company making regenerative skin therapies and a medical school research center are developing a spray-on treatment for a genetic skin disorder.
-

Cell, Gene Therapy R&D/Mfring Center in Works
A consortium of companies, universities, and hospitals are creating an innovation and manufacturing center in the Boston area for cell and gene therapies.
-

New Antibiotic Discovered to Fight Drug-Resistant Bacteria
Researchers in the U.S. and Germany discovered a new source of antibiotics to fight drug-resistant bacteria from common worms living in soil.
-

Trial Shows Safety, Activity of ALS Stem Cell Therapy
A clinical trial shows a treatment for amyotrophic lateral sclerosis, or ALS, derived from bone marrow stem cells is safe and improves a patient’s condition.
-

First Blood Disorder Crispr Treatments Reported
Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatments helped patients improve their conditions.
-

Anti-Vaccine Groups More Adept at Facebook Ads
A review of advertisements about vaccinations shows a few groups took advantage of Facebook’s advertising policies to spread vaccine misinformation.
-

T-Cells Engineered to Release Anti-Cancer Proteins
A biotechnology company is developing modified immune system cells programmed to sense and respond to cancer cells with targeted therapeutic proteins.